Seeing More, Achieving More with Bluesight

lucasBlog

Has your team outgrown your current tools and software in the hospital pharmacy? It’s time to upgrade to a solution that evolves with you, and one that helps facilitate cross-departmental communication and workflow efficiency. The answer is Bluesight: a solution that brings simplicity, visibility, and predictability to your controlled substance management. The best thing about our end-to-end solution is that … Read More

Diversion Quarterly — Q3 2020

Olivia StearnBlog

Kit Check is sharing data from its Bluesight™ for Controlled Substances platform on a quarterly basis to provide insight into the types of diversions and investigations that may be occurring in hospital pharmacies. The following information is as of September 30, 2020. Data was pulled from health systems across the United States.

Introducing Beju Shah, Kit Check’s New Director of Clinical Solutions

Olivia StearnBlog

Beju’s career thus far has provided him a unique set of skills – he’s equipped with deep knowledge of all aspects of pharmacy medication use processes, from frontline patient-centered care to data-driven analytics and system-based thinking, and he’s able to blend this knowledge to offer pragmatic solutions in response to issues within the industry.

Kit Check and Sandoz Collaborate to Launch RFID-tagged Generic Injectables in October 2020

Olivia StearnPress Release

DoseID members, Kit Check and Sandoz, have agreed to launch RFID-tagged injectable medicines Two NDCs of Sandoz RFID-tagged medicines will be available in October 2020, with several more available through Q1 2021 The RFID-tagged medicines are registered into the cloud-based Registry at the site of production and can be scanned in downstream Kit Check scanning stations in hospitals to ensure … Read More

DoseID in Healthcare Tech Outlook

Olivia StearnBlog

Kit Check is a founding member of DoseID, the pharmaceutical industry’s first consortium around best practices for the use of RFID. Healthcare Tech Outlook explores the ways that “DoseID is a more comprehensive answer to the calls for supply chain modernization”.

Diversion Quarterly — Q2 2020

Olivia StearnBlog

Kit Check is pulling data from its Bluesight™ for Controlled Substances platform on a quarterly basis to provide insight into the types of diversions and investigations that may be occurring in hospital pharmacies. The following information is as of June 30, 2020. Data was pulled from health systems across the United States.

BCS Summer 2020 Release

Olivia StearnBlog

The latest BCS features, released Summer 2020, are single sign on, a newly improved pharmacy module, and system benchmarking. Together, these three features give hospitals a powerful, efficient look at current practices plus recommendations for improvement.